| 09:00 | Drug delivery systems for glaucoma: an overview | ZEYEN T | ||||||
| 09:15 | Enzymatic vitreolysis with ocriplasmin | STALMANS P | ||||||
| 09:30 | Off-label use: Avastin versus Lucentis | DE ZAEYTIJD J | ||||||
| 09:45 | The future in treatment of DRP and retinal vein occlusion | VAN CALSTER J | ||||||
| 10:00 | The future in AMD treatment | LEYS A | ||||||
| 10:15 | Discussion | |||||||
| 10:30 | Break | |||||||
| 11:00 | Off-label use in uveitis treatment: what's available? | DE SCHRYVER I | ||||||
| 11:15 | The future in uveitis treatment | ZIERHUT M | ||||||
| 11:30 | Off-label use in glaucoma treatment | STALMANS I | ||||||
| 11:45 | The future in glaucoma treatment | HONDEGHEM K | ||||||
|   | ||||||||
| 12:20 | Discussion | |||||||
| 12:30 | End of session | |||||||